Great Lakes Advisors LLC Reduces Holdings in AdaptHealth Corp. (NASDAQ:AHCO)

Great Lakes Advisors LLC reduced its stake in AdaptHealth Corp. (NASDAQ:AHCO - Free Report) by 75.5% during the fourth quarter, according to its most recent filing with the SEC. The fund owned 118,018 shares of the company's stock after selling 363,254 shares during the quarter. Great Lakes Advisors LLC owned 0.09% of AdaptHealth worth $860,000 at the end of the most recent quarter.

Several other institutional investors also recently added to or reduced their stakes in the stock. Campbell & CO Investment Adviser LLC purchased a new position in AdaptHealth in the third quarter valued at about $100,000. Raymond James & Associates purchased a new position in AdaptHealth in the third quarter valued at approximately $101,000. Everence Capital Management Inc. bought a new position in AdaptHealth during the fourth quarter valued at $102,000. Zurcher Kantonalbank Zurich Cantonalbank increased its position in AdaptHealth by 53.8% in the third quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 14,507 shares of the company's stock worth $132,000 after buying an additional 5,073 shares during the last quarter. Finally, Corton Capital Inc. bought a new stake in shares of AdaptHealth in the third quarter valued at $147,000. Institutional investors own 82.67% of the company's stock.

Wall Street Analyst Weigh In

Several research firms have recently weighed in on AHCO. UBS Group increased their price target on AdaptHealth from $9.00 to $13.00 and gave the stock a "buy" rating in a research note on Wednesday, February 28th. Royal Bank of Canada reiterated an "outperform" rating and set a $13.00 target price on shares of AdaptHealth in a research report on Monday, March 4th. Finally, Truist Financial reissued a "buy" rating and issued a $13.00 price target on shares of AdaptHealth in a research report on Wednesday, May 15th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating and three have issued a buy rating to the company's stock. According to data from MarketBeat, the company has a consensus rating of "Hold" and a consensus target price of $12.42.

Insider Transactions at AdaptHealth

In other news, major shareholder James E. Flynn sold 182,607 shares of the business's stock in a transaction dated Monday, March 11th. The stock was sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the completion of the transaction, the insider now owns 11,643,769 shares of the company's stock, valued at $128,314,334.38. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. In other news, major shareholder James E. Flynn sold 182,607 shares of AdaptHealth stock in a transaction on Monday, March 11th. The shares were sold at an average price of $11.02, for a total transaction of $2,012,329.14. Following the completion of the sale, the insider now directly owns 11,643,769 shares of the company's stock, valued at approximately $128,314,334.38. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, major shareholder James E. Flynn sold 52,487 shares of the stock in a transaction on Friday, March 8th. The shares were sold at an average price of $10.93, for a total value of $573,682.91. Following the completion of the transaction, the insider now directly owns 11,826,376 shares in the company, valued at approximately $129,262,289.68. The disclosure for this sale can be found here. Insiders own 4.43% of the company's stock.

AdaptHealth Price Performance

Shares of AHCO traded down $0.04 during midday trading on Wednesday, hitting $9.72. 532,121 shares of the company traded hands, compared to its average volume of 1,087,786. AdaptHealth Corp. has a one year low of $6.37 and a one year high of $15.37. The firm has a market cap of $1.29 billion, a P/E ratio of -1.84, a PEG ratio of 0.76 and a beta of 1.06. The company has a debt-to-equity ratio of 1.48, a current ratio of 1.33 and a quick ratio of 1.11. The stock has a 50-day moving average of $10.19 and a 200-day moving average of $8.74.

AdaptHealth (NASDAQ:AHCO - Get Free Report) last issued its quarterly earnings data on Tuesday, February 27th. The company reported $0.64 EPS for the quarter, beating the consensus estimate of $0.20 by $0.44. AdaptHealth had a negative net margin of 21.45% and a positive return on equity of 8.47%. The company had revenue of $858.23 million during the quarter, compared to analysts' expectations of $825.94 million. As a group, sell-side analysts predict that AdaptHealth Corp. will post 0.8 EPS for the current fiscal year.

AdaptHealth Company Profile

AdaptHealth Corp., together with its subsidiaries, sells home medical equipment (HME), medical supplies, and home and related services in the United States. The company provides sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs.